KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Payables: 2009-2025

Historic Payables for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to $129.4 million.

  • Exact Sciences' Payables fell 62.69% to $129.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $767.6 million, marking a year-over-year decrease of 25.96%. This contributed to the annual value of $338.7 million for FY2024, which is 329.77% up from last year.
  • As of Q3 2025, Exact Sciences' Payables stood at $129.4 million, which was down 17.78% from $157.3 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Payables registered a high of $354.8 million during Q3 2021, and its lowest value of $63.6 million during Q3 2022.
  • Moreover, its 3-year median value for Payables was $142.2 million (2025), whereas its average is $185.4 million.
  • Its Payables has fluctuated over the past 5 years, first spiked by 1,195.91% in 2021, then crashed by 82.08% in 2022.
  • Over the past 5 years, Exact Sciences' Payables (Quarterly) stood at $67.8 million in 2021, then grew by 10.45% to $74.9 million in 2022, then climbed by 5.21% to $78.8 million in 2023, then spiked by 329.77% to $338.7 million in 2024, then tumbled by 62.69% to $129.4 million in 2025.
  • Its last three reported values are $129.4 million in Q3 2025, $157.3 million for Q2 2025, and $142.2 million during Q1 2025.